Global Neurodiagnostic And Monitoring Devices
Global Neurodiagnostic And Monitoring Devices

Neurodiagnostic And Monitoring Devices Comprehensive Study by Application (Alzheimer’s disease, Migraine, Multiple Sclerosis), Product Type (Magnetoencephalography (MEG), Electromyography (EMG), Transcranial Cerebral Oximeters, Electroencephalogram (EEG), Cerebral Oximeters, Intracranial Pressure Monitor), End User (Operation Theatres, Hospitals, Clinics, Neurophysiological Laboratories) Players and Region - Global Market Outlook to 2027

Neurodiagnostic And Monitoring Devices Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Apr 2022 Edition 206 Pages 184 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Neurodiagnostic And Monitoring Devices?
For the diagnosis of neurological illnesses such as stroke, migraine, epilepsy, Parkinson's disease, and ischemic stroke, neurodiagnostic and monitoring devices are used. CT scanners, MRI scanners, PET scanners, and other medical devices are examples of these gadgets. These include tools that directly measure brain functioning, such as via electroencephalography (EEG). Diagnostic tests and procedures are essential tools for doctors to confirm or rule out a neurological problem or other medical issue. For many neurological illnesses a century ago, the only way to make a definitive diagnosis was to do an autopsy after someone had died. Scientists can now examine the living brain and monitor nervous system activity in real-time thanks to new devices and methodologies. Doctors now have more powerful and accurate instruments to better diagnose disease and measure the efficacy of a treatment.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledDelsys (United States), Electrical Geodesic Inc. (United States), Elmiko (Europe), LifeLines Neurodiagnostic Systems (United States), Blackrock NeuroMed (United States), Cadwell Laboratories (United States), Compumedics (Australia), CTF MEG NEURO INNOVATIONS, INC. (Canada), Motion Lab Systems (United States) and Natus Medical (United States)
CAGR%


The market study is broken down, by Application (Alzheimer’s disease, Migraine and Multiple Sclerosis) and major geographies with country level break-up.

The Neurodiagnostic and Monitoring Devices market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, growing demand of safe and secure vehicles, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Neurodiagnostic And Monitoring Devices market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Delsys (United States), Electrical Geodesic Inc. (United States), Elmiko (Europe), LifeLines Neurodiagnostic Systems (United States), Blackrock NeuroMed (United States), Cadwell Laboratories (United States), Compumedics (Australia), CTF MEG NEURO INNOVATIONS, INC. (Canada), Motion Lab Systems (United States) and Natus Medical (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Neurodiagnostic And Monitoring Devices market by Type, Application and Region.

On the basis of geography, the market of Neurodiagnostic And Monitoring Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Product Type, the sub-segment i.e. Magnetoencephalography (MEG) will boost the Neurodiagnostic And Monitoring Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Operation Theatres will boost the Neurodiagnostic And Monitoring Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

In October 2021- Royal Philips a global leader in health technology announced that the Philips Capsule Medical Device Information Platform (MDIP) has now integrated with over 1,000 unique medical device models, thanks to the release of new device drivers that enable integration and interoperability. More than 3,000 healthcare facilities around the world have Philips Capsule MDIP, which will be linked to the Philips HealthSuite Platform. Philips Capsule MDIP takes streaming clinical data and converts it into meaningful insights for patient care management, with the goal of improving care team cooperation, streamlining clinical workflows, and increasing productivity.


Market Trend
  • Growing demand for EEG procedures

Market Drivers
  • Increase in prevalence of neurological disorders
  • Increasing prevalence of diseases due to viral infections, genetic factors, and the lack of immune response

Opportunities
  • The increasing demand for non-invasive and minimally invasive devices

Restraints
  • The Costs of Neurodiagnostic Procedures and Devices Are Very High

Challenges
  • Adopting a proper theoretical framework of emotion
  • Decoding affective state accurately and continuously


Key Target Audience
Industry associations., Research organizations and consulting companies., Organizations, associations, and alliances related to the Rotator Cuff Repair Device market industry., Neurodiagnostic and Monitoring Devices market companies. and Hospitals.

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Frequently Asked Questions (FAQ):

1. What all players are profiled in the study?
The standard version of the report profiles players such as Delsys (United States), Electrical Geodesic Inc. (United States), Elmiko (Europe), LifeLines Neurodiagnostic Systems (United States), Blackrock NeuroMed (United States), Cadwell Laboratories (United States), Compumedics (Australia), CTF MEG NEURO INNOVATIONS, INC. (Canada), Motion Lab Systems (United States) and Natus Medical (United States) etc.

2. Can we have customized study for Neurodiagnostic And Monitoring Devices Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

3. What would be the Market Size of Neurodiagnostic And Monitoring Devices Market by 2027?
Analysts at AMA estimates Neurodiagnostic And Monitoring Devices Market to reach USD Million by 2027.
Report Objectives / Segmentation Covered
By Application
  • Alzheimer’s disease
  • Migraine
  • Multiple Sclerosis
By Product Type
  • Magnetoencephalography (MEG)
  • Electromyography (EMG)
  • Transcranial Cerebral Oximeters
  • Electroencephalogram (EEG)
  • Cerebral Oximeters
  • Intracranial Pressure Monitor

By End User
  • Operation Theatres
  • Hospitals
  • Clinics
  • Neurophysiological Laboratories

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in prevalence of neurological disorders
      • 3.2.2. Increasing prevalence of diseases due to viral infections, genetic factors, and the lack of immune response
    • 3.3. Market Challenges
      • 3.3.1. Adopting a proper theoretical framework of emotion
      • 3.3.2. Decoding affective state accurately and continuously
    • 3.4. Market Trends
      • 3.4.1. Growing demand for EEG procedures
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Neurodiagnostic And Monitoring Devices, by Application, Product Type, End User and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Neurodiagnostic And Monitoring Devices (Value)
      • 5.2.1. Global Neurodiagnostic And Monitoring Devices by: Application (Value)
        • 5.2.1.1. Alzheimer’s disease
        • 5.2.1.2. Migraine
        • 5.2.1.3. Multiple Sclerosis
      • 5.2.2. Global Neurodiagnostic And Monitoring Devices by: Product Type (Value)
        • 5.2.2.1. Magnetoencephalography (MEG)
        • 5.2.2.2. Electromyography (EMG)
        • 5.2.2.3. Transcranial Cerebral Oximeters
        • 5.2.2.4. Electroencephalogram (EEG)
        • 5.2.2.5. Cerebral Oximeters
        • 5.2.2.6. Intracranial Pressure Monitor
      • 5.2.3. Global Neurodiagnostic And Monitoring Devices by: End User (Value)
        • 5.2.3.1. Operation Theatres
        • 5.2.3.2. Hospitals
        • 5.2.3.3. Clinics
        • 5.2.3.4. Neurophysiological Laboratories
      • 5.2.4. Global Neurodiagnostic And Monitoring Devices Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Neurodiagnostic And Monitoring Devices (Price)
  • 6. Neurodiagnostic And Monitoring Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Delsys (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Electrical Geodesic Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Elmiko (Europe)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. LifeLines Neurodiagnostic Systems (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Blackrock NeuroMed (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cadwell Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Compumedics (Australia)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. CTF MEG NEURO INNOVATIONS, INC. (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Motion Lab Systems (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Natus Medical (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Neurodiagnostic And Monitoring Devices Sale, by Application, Product Type, End User and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Neurodiagnostic And Monitoring Devices (Value)
      • 7.2.1. Global Neurodiagnostic And Monitoring Devices by: Application (Value)
        • 7.2.1.1. Alzheimer’s disease
        • 7.2.1.2. Migraine
        • 7.2.1.3. Multiple Sclerosis
      • 7.2.2. Global Neurodiagnostic And Monitoring Devices by: Product Type (Value)
        • 7.2.2.1. Magnetoencephalography (MEG)
        • 7.2.2.2. Electromyography (EMG)
        • 7.2.2.3. Transcranial Cerebral Oximeters
        • 7.2.2.4. Electroencephalogram (EEG)
        • 7.2.2.5. Cerebral Oximeters
        • 7.2.2.6. Intracranial Pressure Monitor
      • 7.2.3. Global Neurodiagnostic And Monitoring Devices by: End User (Value)
        • 7.2.3.1. Operation Theatres
        • 7.2.3.2. Hospitals
        • 7.2.3.3. Clinics
        • 7.2.3.4. Neurophysiological Laboratories
      • 7.2.4. Global Neurodiagnostic And Monitoring Devices Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Neurodiagnostic And Monitoring Devices (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Neurodiagnostic And Monitoring Devices: by Application(USD Million)
  • Table 2. Neurodiagnostic And Monitoring Devices Alzheimer’s disease , by Region USD Million (2016-2021)
  • Table 3. Neurodiagnostic And Monitoring Devices Migraine , by Region USD Million (2016-2021)
  • Table 4. Neurodiagnostic And Monitoring Devices Multiple Sclerosis , by Region USD Million (2016-2021)
  • Table 5. Neurodiagnostic And Monitoring Devices: by Product Type(USD Million)
  • Table 6. Neurodiagnostic And Monitoring Devices Magnetoencephalography (MEG) , by Region USD Million (2016-2021)
  • Table 7. Neurodiagnostic And Monitoring Devices Electromyography (EMG) , by Region USD Million (2016-2021)
  • Table 8. Neurodiagnostic And Monitoring Devices Transcranial Cerebral Oximeters , by Region USD Million (2016-2021)
  • Table 9. Neurodiagnostic And Monitoring Devices Electroencephalogram (EEG) , by Region USD Million (2016-2021)
  • Table 10. Neurodiagnostic And Monitoring Devices Cerebral Oximeters , by Region USD Million (2016-2021)
  • Table 11. Neurodiagnostic And Monitoring Devices Intracranial Pressure Monitor , by Region USD Million (2016-2021)
  • Table 12. Neurodiagnostic And Monitoring Devices: by End User(USD Million)
  • Table 13. Neurodiagnostic And Monitoring Devices Operation Theatres , by Region USD Million (2016-2021)
  • Table 14. Neurodiagnostic And Monitoring Devices Hospitals , by Region USD Million (2016-2021)
  • Table 15. Neurodiagnostic And Monitoring Devices Clinics , by Region USD Million (2016-2021)
  • Table 16. Neurodiagnostic And Monitoring Devices Neurophysiological Laboratories , by Region USD Million (2016-2021)
  • Table 17. South America Neurodiagnostic And Monitoring Devices, by Country USD Million (2016-2021)
  • Table 18. South America Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 19. South America Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 20. South America Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 21. Brazil Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 22. Brazil Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 23. Brazil Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 24. Argentina Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 25. Argentina Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 26. Argentina Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 27. Rest of South America Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 28. Rest of South America Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 29. Rest of South America Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 30. Asia Pacific Neurodiagnostic And Monitoring Devices, by Country USD Million (2016-2021)
  • Table 31. Asia Pacific Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 32. Asia Pacific Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 33. Asia Pacific Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 34. China Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 35. China Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 36. China Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 37. Japan Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 38. Japan Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 39. Japan Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 40. India Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 41. India Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 42. India Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 43. South Korea Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 44. South Korea Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 45. South Korea Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 46. Taiwan Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 47. Taiwan Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 48. Taiwan Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 49. Australia Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 50. Australia Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 51. Australia Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 52. Rest of Asia-Pacific Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 53. Rest of Asia-Pacific Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 54. Rest of Asia-Pacific Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 55. Europe Neurodiagnostic And Monitoring Devices, by Country USD Million (2016-2021)
  • Table 56. Europe Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 57. Europe Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 58. Europe Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 59. Germany Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 60. Germany Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 61. Germany Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 62. France Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 63. France Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 64. France Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 65. Italy Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 66. Italy Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 67. Italy Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 68. United Kingdom Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 69. United Kingdom Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 70. United Kingdom Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 71. Netherlands Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 72. Netherlands Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 73. Netherlands Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 74. Rest of Europe Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 75. Rest of Europe Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 76. Rest of Europe Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 77. MEA Neurodiagnostic And Monitoring Devices, by Country USD Million (2016-2021)
  • Table 78. MEA Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 79. MEA Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 80. MEA Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 81. Middle East Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 82. Middle East Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 83. Middle East Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 84. Africa Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 85. Africa Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 86. Africa Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 87. North America Neurodiagnostic And Monitoring Devices, by Country USD Million (2016-2021)
  • Table 88. North America Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 89. North America Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 90. North America Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 91. United States Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 92. United States Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 93. United States Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 94. Canada Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 95. Canada Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 96. Canada Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 97. Mexico Neurodiagnostic And Monitoring Devices, by Application USD Million (2016-2021)
  • Table 98. Mexico Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2016-2021)
  • Table 99. Mexico Neurodiagnostic And Monitoring Devices, by End User USD Million (2016-2021)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Neurodiagnostic And Monitoring Devices: by Application(USD Million)
  • Table 111. Neurodiagnostic And Monitoring Devices Alzheimer’s disease , by Region USD Million (2022-2027)
  • Table 112. Neurodiagnostic And Monitoring Devices Migraine , by Region USD Million (2022-2027)
  • Table 113. Neurodiagnostic And Monitoring Devices Multiple Sclerosis , by Region USD Million (2022-2027)
  • Table 114. Neurodiagnostic And Monitoring Devices: by Product Type(USD Million)
  • Table 115. Neurodiagnostic And Monitoring Devices Magnetoencephalography (MEG) , by Region USD Million (2022-2027)
  • Table 116. Neurodiagnostic And Monitoring Devices Electromyography (EMG) , by Region USD Million (2022-2027)
  • Table 117. Neurodiagnostic And Monitoring Devices Transcranial Cerebral Oximeters , by Region USD Million (2022-2027)
  • Table 118. Neurodiagnostic And Monitoring Devices Electroencephalogram (EEG) , by Region USD Million (2022-2027)
  • Table 119. Neurodiagnostic And Monitoring Devices Cerebral Oximeters , by Region USD Million (2022-2027)
  • Table 120. Neurodiagnostic And Monitoring Devices Intracranial Pressure Monitor , by Region USD Million (2022-2027)
  • Table 121. Neurodiagnostic And Monitoring Devices: by End User(USD Million)
  • Table 122. Neurodiagnostic And Monitoring Devices Operation Theatres , by Region USD Million (2022-2027)
  • Table 123. Neurodiagnostic And Monitoring Devices Hospitals , by Region USD Million (2022-2027)
  • Table 124. Neurodiagnostic And Monitoring Devices Clinics , by Region USD Million (2022-2027)
  • Table 125. Neurodiagnostic And Monitoring Devices Neurophysiological Laboratories , by Region USD Million (2022-2027)
  • Table 126. South America Neurodiagnostic And Monitoring Devices, by Country USD Million (2022-2027)
  • Table 127. South America Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 128. South America Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 129. South America Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 130. Brazil Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 131. Brazil Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 132. Brazil Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 133. Argentina Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 134. Argentina Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 135. Argentina Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 136. Rest of South America Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 137. Rest of South America Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 138. Rest of South America Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 139. Asia Pacific Neurodiagnostic And Monitoring Devices, by Country USD Million (2022-2027)
  • Table 140. Asia Pacific Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 141. Asia Pacific Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 142. Asia Pacific Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 143. China Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 144. China Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 145. China Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 146. Japan Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 147. Japan Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 148. Japan Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 149. India Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 150. India Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 151. India Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 152. South Korea Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 153. South Korea Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 154. South Korea Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 155. Taiwan Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 156. Taiwan Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 157. Taiwan Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 158. Australia Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 159. Australia Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 160. Australia Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 161. Rest of Asia-Pacific Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 162. Rest of Asia-Pacific Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 163. Rest of Asia-Pacific Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 164. Europe Neurodiagnostic And Monitoring Devices, by Country USD Million (2022-2027)
  • Table 165. Europe Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 166. Europe Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 167. Europe Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 168. Germany Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 169. Germany Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 170. Germany Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 171. France Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 172. France Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 173. France Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 174. Italy Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 175. Italy Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 176. Italy Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 177. United Kingdom Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 178. United Kingdom Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 179. United Kingdom Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 180. Netherlands Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 181. Netherlands Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 182. Netherlands Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 183. Rest of Europe Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 184. Rest of Europe Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 185. Rest of Europe Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 186. MEA Neurodiagnostic And Monitoring Devices, by Country USD Million (2022-2027)
  • Table 187. MEA Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 188. MEA Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 189. MEA Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 190. Middle East Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 191. Middle East Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 192. Middle East Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 193. Africa Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 194. Africa Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 195. Africa Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 196. North America Neurodiagnostic And Monitoring Devices, by Country USD Million (2022-2027)
  • Table 197. North America Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 198. North America Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 199. North America Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 200. United States Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 201. United States Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 202. United States Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 203. Canada Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 204. Canada Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 205. Canada Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 206. Mexico Neurodiagnostic And Monitoring Devices, by Application USD Million (2022-2027)
  • Table 207. Mexico Neurodiagnostic And Monitoring Devices, by Product Type USD Million (2022-2027)
  • Table 208. Mexico Neurodiagnostic And Monitoring Devices, by End User USD Million (2022-2027)
  • Table 209. Research Programs/Design for This Report
  • Table 210. Key Data Information from Secondary Sources
  • Table 211. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Neurodiagnostic And Monitoring Devices: by Application USD Million (2016-2021)
  • Figure 5. Global Neurodiagnostic And Monitoring Devices: by Product Type USD Million (2016-2021)
  • Figure 6. Global Neurodiagnostic And Monitoring Devices: by End User USD Million (2016-2021)
  • Figure 7. South America Neurodiagnostic And Monitoring Devices Share (%), by Country
  • Figure 8. Asia Pacific Neurodiagnostic And Monitoring Devices Share (%), by Country
  • Figure 9. Europe Neurodiagnostic And Monitoring Devices Share (%), by Country
  • Figure 10. MEA Neurodiagnostic And Monitoring Devices Share (%), by Country
  • Figure 11. North America Neurodiagnostic And Monitoring Devices Share (%), by Country
  • Figure 12. Global Neurodiagnostic And Monitoring Devices share by Players 2021 (%)
  • Figure 13. Global Neurodiagnostic And Monitoring Devices share by Players (Top 3) 2021(%)
  • Figure 14. Global Neurodiagnostic And Monitoring Devices share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Delsys (United States) Revenue, Net Income and Gross profit
  • Figure 17. Delsys (United States) Revenue: by Geography 2021
  • Figure 18. Electrical Geodesic Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Electrical Geodesic Inc. (United States) Revenue: by Geography 2021
  • Figure 20. Elmiko (Europe) Revenue, Net Income and Gross profit
  • Figure 21. Elmiko (Europe) Revenue: by Geography 2021
  • Figure 22. LifeLines Neurodiagnostic Systems (United States) Revenue, Net Income and Gross profit
  • Figure 23. LifeLines Neurodiagnostic Systems (United States) Revenue: by Geography 2021
  • Figure 24. Blackrock NeuroMed (United States) Revenue, Net Income and Gross profit
  • Figure 25. Blackrock NeuroMed (United States) Revenue: by Geography 2021
  • Figure 26. Cadwell Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 27. Cadwell Laboratories (United States) Revenue: by Geography 2021
  • Figure 28. Compumedics (Australia) Revenue, Net Income and Gross profit
  • Figure 29. Compumedics (Australia) Revenue: by Geography 2021
  • Figure 30. CTF MEG NEURO INNOVATIONS, INC. (Canada) Revenue, Net Income and Gross profit
  • Figure 31. CTF MEG NEURO INNOVATIONS, INC. (Canada) Revenue: by Geography 2021
  • Figure 32. Motion Lab Systems (United States) Revenue, Net Income and Gross profit
  • Figure 33. Motion Lab Systems (United States) Revenue: by Geography 2021
  • Figure 34. Natus Medical (United States) Revenue, Net Income and Gross profit
  • Figure 35. Natus Medical (United States) Revenue: by Geography 2021
  • Figure 36. Global Neurodiagnostic And Monitoring Devices: by Application USD Million (2022-2027)
  • Figure 37. Global Neurodiagnostic And Monitoring Devices: by Product Type USD Million (2022-2027)
  • Figure 38. Global Neurodiagnostic And Monitoring Devices: by End User USD Million (2022-2027)
  • Figure 39. South America Neurodiagnostic And Monitoring Devices Share (%), by Country
  • Figure 40. Asia Pacific Neurodiagnostic And Monitoring Devices Share (%), by Country
  • Figure 41. Europe Neurodiagnostic And Monitoring Devices Share (%), by Country
  • Figure 42. MEA Neurodiagnostic And Monitoring Devices Share (%), by Country
  • Figure 43. North America Neurodiagnostic And Monitoring Devices Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Delsys (United States)
  • Electrical Geodesic Inc. (United States)
  • Elmiko (Europe)
  • LifeLines Neurodiagnostic Systems (United States)
  • Blackrock NeuroMed (United States)
  • Cadwell Laboratories (United States)
  • Compumedics (Australia)
  • CTF MEG NEURO INNOVATIONS, INC. (Canada)
  • Motion Lab Systems (United States)
  • Natus Medical (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation